Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lister strain smallpox vaccine
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Percutaneous
01
Overview
The Lister strain smallpox vaccine (VV LISTER/CEP) is a second-generation, live-attenuated, replication-competent vaccine developed by Sanofi Pasteur for the prevention of smallpox (variola virus). Unlike first-generation vaccines produced in animal skin, this version is propagated in chicken embryo primary (CEP) cells to improve purity and consistency. It is administered via scarification using a bifurcated needle, inducing cross-protective anti-vaccinia antibodies. Developed primarily as a countermeasure against potential bioterrorism, the vaccine has demonstrated safety and immunogenicity profiles comparable to traditional Lister-strain vaccines in clinical trials, with studies confirming antibody persistence for at least five years post-vaccination.
- Other names
- Lister strain smallpox vaccineLister/CEPVV LISTER/CEPsecond-generation smallpox vaccine
Beyond the preview
Go deeper on Lister strain smallpox vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lister strain smallpox vaccine.